SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203101. A total of 1 filers reported holding SOLENO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,051,593 | +200203.4% | 245,127 | 0.0% | 0.79% | +91.7% |
| Q1 2023 | $525 | +8.2% | 245,127 | 0.0% | 0.41% | +19.8% |
| Q4 2022 | $485 | -99.9% | 245,127 | 0.0% | 0.34% | +19.1% |
| Q3 2022 | $409,000 | -39.9% | 245,127 | -93.3% | 0.29% | -41.8% |
| Q2 2022 | $680,000 | -17.1% | 3,676,899 | 0.0% | 0.50% | -16.1% |
| Q1 2022 | $820,000 | +127.8% | 3,676,899 | +319.3% | 0.59% | +154.3% |
| Q4 2021 | $360,000 | -55.6% | 876,899 | 0.0% | 0.23% | -58.0% |
| Q3 2021 | $811,000 | -18.9% | 876,899 | 0.0% | 0.55% | -7.7% |
| Q2 2021 | $1,000,000 | -9.5% | 876,899 | 0.0% | 0.60% | -8.8% |
| Q1 2021 | $1,105,000 | -30.8% | 876,899 | +6.0% | 0.66% | -28.6% |
| Q4 2020 | $1,596,000 | -61.6% | 826,899 | -50.0% | 0.92% | -33.7% |
| Q3 2020 | $4,152,000 | +126.1% | 1,653,798 | +100.0% | 1.39% | +25.0% |
| Q2 2020 | $1,836,000 | +282.5% | 826,899 | +310.4% | 1.11% | +160.6% |
| Q1 2020 | $480,000 | -68.0% | 201,499 | -60.5% | 0.43% | -61.0% |
| Q4 2019 | $1,501,000 | +315.8% | 510,598 | +112.2% | 1.09% | +352.7% |
| Q3 2019 | $361,000 | -46.4% | 240,598 | 0.0% | 0.24% | -41.2% |
| Q2 2019 | $674,000 | +35.9% | 240,598 | 0.0% | 0.41% | +31.8% |
| Q1 2019 | $496,000 | -55.8% | 240,598 | -63.4% | 0.31% | -70.7% |
| Q4 2018 | $1,123,000 | -20.8% | 656,598 | 0.0% | 1.06% | +16.1% |
| Q3 2018 | $1,418,000 | -10.7% | 656,598 | -3.2% | 0.92% | -15.2% |
| Q2 2018 | $1,588,000 | +29.1% | 678,428 | 0.0% | 1.08% | +33.2% |
| Q1 2018 | $1,230,000 | +19.2% | 678,428 | 0.0% | 0.81% | +33.9% |
| Q4 2017 | $1,032,000 | – | 678,428 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 876,899 | $360,000 | 0.23% |